PCNA and MCM 2 in Odontogenic Tumors: An Immunnohistological Study

牙源性肿瘤中PCNA和MCM2的免疫组织化学研究

阅读:1

Abstract

BACKGROUND: The proliferative potential of odontogenic tumors is an important factor in understanding their aggressive behavior. "Proliferating Cell Nuclear Antigen (PCNA)" is a functional and structural component of DNA replication factor, while "Minichromosome Maintenance Protein 2 (MCM2)", from the MCM family, mediates cell proliferation as well as progression through to S-phase. Here, we aimed to evaluate the expression of PCNA and MCM2 in odontogenic tumors with a special emphasis on ameloblastomas and "keratocystic odontogenic tumors (KCOTs)". MATERIALS AND METHODS: Immunohistochemical staining for PCNA and MCM2 was performed in tissue samples of ameloblastoma and KCOT. The expression levels were studied. RESULTS: Both PCNA and MCM2 were overexpressed significantly higher in ameloblastomas compared to KCOT. A strong correlation was also noted between increased MCM2 expression and local invasiveness of tumour (P < 0.05). CONCLUSIONS: We have studied the expression of MCM2 in a series of ameloblastomas (using an immunohistochemical method) and found this marker to be expressed at high levels; thus, it could potentially serve as a prognostic marker for these aggressive tumors.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。